Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Omaha, NE
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Newark, NJ
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
New York, NY
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Cleveland, OH
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Philadelphia, PA
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
(ARFI) Shear Velocity Imaging of the Kidneys in Pediatric Patients
Ultrasound Based Acoustic Radiation Force Impulse (ARFI)Shear Wave Velocity Imaging (SVI)of the Kidneys in Pediatric Patients With Vesicoureteral Reflux
Status: Enrolling
Updated:  10/24/2013
University of Michigan
mi
from
Ann Arbor, MI
(ARFI) Shear Velocity Imaging of the Kidneys in Pediatric Patients
Ultrasound Based Acoustic Radiation Force Impulse (ARFI)Shear Wave Velocity Imaging (SVI)of the Kidneys in Pediatric Patients With Vesicoureteral Reflux
Status: Enrolling
Updated: 10/24/2013
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy of Gralise® for Chronic Pelvic Pain
Efficacy of Gralise® for Chronic Pelvic Pain
Status: Enrolling
Updated:  10/29/2013
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Efficacy of Gralise® for Chronic Pelvic Pain
Efficacy of Gralise® for Chronic Pelvic Pain
Status: Enrolling
Updated: 10/29/2013
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Huntsville, AL
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Phoenix, AZ
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
San Diego, CA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Colorado Springs, CO
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
New London, CT
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
New London, CT
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Boynton Beach, FL
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcottt Investigational Study Site
mi
from
Clearwater, FL
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcottt Investigational Study Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Atlanta, GA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Coeur d'Alene, ID
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Chicago, IL
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Site
mi
from
Granger, IN
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Site
mi
from
Granger, IN
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
West Des Moines, IA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Overland Park, KA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Marrero, LA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Marrero, LA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Elkridge, MD
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Elkridge, MD
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Brookline, MA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Brookline, MA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Omaha, NE
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Las Vegas, NV
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Moorestown, NJ
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Moorestown, NJ
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Albuquerque, NM
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Purchase, NY
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Purchase, NY
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Greensboro, NC
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Cleveland, OH
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Jenkintown, PA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Warwick, RI
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Warwick, RI
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Bluffton, SC
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Bluffton, SC
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Bristol, TN
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Bristol, TN
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Dallas, TX
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Salt Lake City, UT
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Norfolk, VA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Seattle, WA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Wauwatosa, WI
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Sensory Processing in Subjects With Painful Bladder Syndrome
Sensory Processing in Subjects With Painful Bladder Syndrome
Status: Enrolling
Updated:  11/22/2013
Kirklin Clinic Urology Clinic
mi
from
Birmingham, AL
Sensory Processing in Subjects With Painful Bladder Syndrome
Sensory Processing in Subjects With Painful Bladder Syndrome
Status: Enrolling
Updated: 11/22/2013
Kirklin Clinic Urology Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Glendale, AL
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Glendale, AL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Homewood, AL
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Homewood, AL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Mobile, AL
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Mobile, AL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Phoenix, AZ
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Glendora, CA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Glendora, CA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Murrieta, CA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Murrieta, CA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
San Diego, CA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
San Diego, CA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Farmington, CT
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Farmington, CT
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
New Britain, CT
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
New Britain, CT
Click here to add this to my saved trials